Upgrade to SI Premium - Free Trial

Wedbush Recommends Buying Sangamo BioSciences (SGMO) on Weakness

August 6, 2015 1:07 PM
Wedbush analyst Liana Moussatos is out defending Sangamo BioSciences (NASDAQ: SGMO) mid-day with shares getting sliced to the tune of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View

Next Articles